The grant, which is the second this year for the TB alliance from the Government of Ireland, comes at a time of great concern from World Health authorities over a substantial rise in the number of multiple and drug resistant strains of TB.
The money will be used over a period of three years to advance the completion of two clinical trials of TB drugs which have the potential to reduce treatment times by half in the future.
For more information please contact the TB alliance.
Related EPHA articles
Open Forum on Key Issues in Tuberculosis Drug Development
